SITAGLIPTIN MYLAN sitagliptin (as hydrochloride monohydrate) 100 mg tablet blister pack

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

sitagliptin hydrochloride monohydrate, Quantity: 113.376 mg (Equivalent: sitagliptin, Qty 100 mg)

Dostupné s:

Maple Healthcare Pty Ltd

Léková forma:

Tablet, film coated

Složení:

Excipient Ingredients: calcium hydrogen phosphate; microcrystalline cellulose; croscarmellose sodium; sodium stearylfumarate; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350

Podání:

Oral

Jednotky v balení:

28 tablets

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

sitagliptin hydrochloride monohydrate is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin

Přehled produktů:

Visual Identification: beige round shape biconvex film coated tablets debossed with L on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PVDC; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stav Autorizace:

Registered

Datum autorizace:

2023-04-05